MT Newswires on MSN10h
Investors Await Key Inflation Data as US Futures Trend Higher Pre-Bell
US stock futures were tracking higher in Tuesday's premarket session as investors awaited key inflation data. Dow Jones Industrial Average futures were up 0.27%, S&P 500 futures were 0.30% higher, and ...
Pharmabiz4d
Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension
Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...
Mineralys Therapeutics Advances Lorundrostat to Phase 2 Trials
An update from Mineralys Therapeutics, Inc. ( (MLYS) ) is now available. Mineralys Therapeutics announced that the U.S. FDA ...
Hosted on MSN5d
Mineralys Therapeutics Receives FDA Clearance for Phase 2 Trial of Lorundrostat in Treating Sleep Apnea and Hypertension
RADNOR, PA — Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its ...
Strategic Advancements and FDA Clearance Propel Mineralys Therapeutics to a Buy Rating
Mineralys Therapeutics, Inc. (MLYS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
marketinference6d
FDA Clears Mineralys Therapeutics' IND for OSA and Hypertension Trial
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced the clearance of its investigational new drug (IND) application by ...
Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...